Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Market Cap	24.75B
Revenue (ttm)	2.12B
Net Income (ttm)	415.38M
Shares Out	n/a
EPS (ttm)	0.55
PE Ratio	59.57
Forward PE	132.03
Dividend	0.00 (0.01%)
Ex-Dividend Date	Jun 26, 2025

Volume	9,397,857
Average Volume	8,430,591
Open	25.10
Previous Close	24.40
Day's Range	23.70 - 26.50
52-Week Range	6.31 - 26.10
Beta	0.72
RSI	81.48
Earnings Date	Aug 27, 2025

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,652
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6127

Financial Performance

In 2024, HKG:6127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial numbers in CNY